These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 23780578

  • 1. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 2. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 3. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 12; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 4. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

  • 5. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Nov 30; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 6. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T, Nahler A, Reiter C, Gammer V, Blessberger H, Kammler J, Grund M, Saleh K, Schwarz S, Steinwender C.
    Catheter Cardiovasc Interv; 2015 Sep 30; 86(3):E126-30. PubMed ID: 26033366
    [Abstract] [Full Text] [Related]

  • 7. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C.
    Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527
    [Abstract] [Full Text] [Related]

  • 8. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F.
    Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557
    [Abstract] [Full Text] [Related]

  • 9. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K, Buchmayr G, Saleh K, Kammler J, Steinwender C.
    Clin Cardiol; 2014 May 11; 37(5):307-11. PubMed ID: 24700288
    [Abstract] [Full Text] [Related]

  • 10. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
    Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A.
    Kardiol Pol; 2016 May 11; 74(9):961-8. PubMed ID: 27160171
    [Abstract] [Full Text] [Related]

  • 11. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.
    Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, Laufs U, Mahfoud F, Böhm M.
    J Am Coll Cardiol; 2014 May 13; 63(18):1916-23. PubMed ID: 24315919
    [Abstract] [Full Text] [Related]

  • 12. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 13; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 13. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug 13; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

  • 14. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 15. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul 01; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 16. Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
    Schwerg M, Heupel C, Strajnic D, Baumann G, Laule M, Stangl V, Stangl K.
    J Clin Hypertens (Greenwich); 2014 Jun 01; 16(6):406-11. PubMed ID: 24766570
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar 01; 30(1-2):207-20. PubMed ID: 23077975
    [Abstract] [Full Text] [Related]

  • 18. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J.
    Hypertension; 2016 Feb 01; 67(2):397-403. PubMed ID: 26693818
    [Abstract] [Full Text] [Related]

  • 19. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr 01; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 20. Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension.
    Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F.
    Hypertension; 2015 Jan 01; 65(1):193-9. PubMed ID: 25331843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.